IDIBELL, University Hospital of Bellvitge and the Polytechnic University of Catalonia (UPC) have signed a cooperation agreement in the field of education, research and innovation to share knowledge and needs that will allow the development of new health technologies. The agreement establishes a framework for relations between the three institutions for future collaboration in order […]
Past April 1st, 2nd and 3rd, students in 1 º ESO at IES Joan Corominas, Premia de Mar and students of 3 º ESO at IES Montjuïc, Barcelona discovered how our brain changes and also how sometimes it deceives us. They participated in the activity ‘ Brain plasticine’ organized by the research group cognition and
Brain plasticine’ is back Read More »
On Wednesday April 2, the auditorium of the University Hospital of Bellvitge hosted the presentation of the new IDIBELL general manager, Jaume Reventós. The event was attended by members of the delegate Commission of the institution Jordi Alberch , Vice Chancellor of the University of Barcelona ; Alfredo Garcia Director of the University Hospital of
Jaume Reventós: “Together we can move forward” Read More »
Research shows that in one in four human tumor exist genetic polymorphisms associated with increased risk of cancer that cause epigenetic changes that modifies the expression of neighboring genes.
Identified epigenetic factors associated with an increased risk of developing cancer Read More »
NOX4 enzyme inhibits the growth of tumor cells in liver Article reference The NADPH oxidase NOX4 inhibits hepatocyte proliferation and liver cancer progression
IDIBELL researchers describe a new tumor suppressor gene in the liver Read More »
On February 27th and 28th the University of Vienna hosted the second workshop of the European project IT-Liver, funded by the Marie Curie ITN (Initial Training Network) program of the European Commission (FP7) and coordinated by the head of the Biological clues of the invasive and metastasic phenotype research group at IDIBELL, Isabel Fabregat. In
3D biotechnology, protagonist of the workshop of the European project IT-LIVER in Vienna Read More »
For almost a hundred years ago is known that cancer cells feel a special appetite for a type of sugar called glucose. The tumor uses this molecule is like the gasoline which depends a sports car to burn faster and grows and multiplies rapidly. It is a little cash process from the energy point of
Discovery of a mechanism that makes tumor cells sugar addicted Read More »
